Characterization of the interaction of FKBP12 with the transforming growth factor-beta type I receptor in vivo

被引:72
|
作者
Okadome, T
Oeda, E
Saitoh, M
Ichijo, H
Moses, HL
Miyazono, K
Kawabata, M
机构
[1] JAPANESE FDN CANC RES,INST CANC,DEPT BIOCHEM,TOSHIMA KU,TOKYO 170,JAPAN
[2] VANDERBILT UNIV,CTR CANC,NASHVILLE,TN 37232
关键词
D O I
10.1074/jbc.271.36.21687
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The type I transforming growth factor-beta receptor (T beta R-I) is the efferent component of the receptor complex, which presumably phosphorylates intracellular targets. FKBP12, a binding protein for FK506 and rapamycin, is shown to associate with the cytoplasmic region of T beta R-I in vitro. In this report, we investigated the interaction of FKBP12 with T beta R-I in vivo. FKBP12 interacts with T beta R-I in mammalian cells as well as in yeast. Ligand addition does not affect the interaction, and both constitutively active and kinase-negative mutants of T beta R-I bind FKBP12. FKBP12 dissociates from T beta PR-I in the presence of a high concentration of FK506. The juxtamembrane region of T beta R-I, containing the major phosphorylation sites by the type II receptor, is required for the interaction. One of the deletion mutants in this region, which was shown to mediate transcriptional response, does not bind FKBP12, suggesting that FKBP12 is not directly involved in TGF-beta signaling. Furthermore T beta R-I does not phosphorylate FKBP12 in vitro, FKBP12 may not be a direct substrate of T beta R-I but possibly modulates the T beta R-I function through its interaction with the regulatory domain of the kinase.
引用
收藏
页码:21687 / 21690
页数:4
相关论文
共 50 条
  • [41] The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors
    Wang, TW
    Li, BY
    Danielson, PD
    Shah, PC
    Rockwell, S
    Lechleider, RJ
    Martin, J
    Manganaro, T
    Donahoe, PK
    CELL, 1996, 86 (03) : 435 - 444
  • [42] THE TRANSFORMING GROWTH FACTOR-BETA RECEPTOR TYPE-III IS A MEMBRANE PROTEOGLYCAN - DOMAIN-STRUCTURE OF THE RECEPTOR
    CHEIFETZ, S
    ANDRES, JL
    MASSAGUE, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1988, 263 (32) : 16984 - 16991
  • [43] Transforming Growth Factor-Beta and Urokinase Type Plasminoge Interplay in Cancer
    Santibanez, Juan F.
    Krstic, Jelena
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2018, 19 (12) : 1155 - 1163
  • [44] A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity
    Feng, XH
    Derynck, R
    EMBO JOURNAL, 1997, 16 (13): : 3912 - 3923
  • [45] Upregulation of transforming growth factor-beta type I receptor by interferon consensus sequence-binding protein in osteosarcoma cells
    Sung, Jee Young
    Yoon, Kyungsil
    Ye, Sang-Kyu
    Goh, Sung-Ho
    Park, Seog-Yun
    Kim, June Hyuk
    Kang, Hyun Guy
    Kim, Yong-Nyun
    Park, Byung-Kiu
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2019, 1866 (05): : 761 - 772
  • [46] Requirement of transforming growth factor-beta (TGF-beta) type II receptor for TGF-beta-induced proliferation and growth
    Zhao, Y
    Young, SL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (05) : 2369 - 2372
  • [47] Transforming growth factor-beta and prostate cancer
    Steiner, MS
    WORLD JOURNAL OF UROLOGY, 1995, 13 (06) : 329 - 336
  • [48] In vivo hyperexpression of transforming growth factor-beta(1) in mice: Stimulation by cyclosporine
    Khanna, A
    Kapur, S
    Sharma, V
    Li, BG
    Suthanthiran, M
    TRANSPLANTATION, 1997, 63 (07) : 1037 - 1039
  • [49] Identification of important regions in the cytoplasmic juxtamembrane domain of type I receptor that separate signaling pathways of transforming growth factor-beta
    Saitoh, M
    Nishitoh, H
    Amagasa, T
    Miyazono, K
    Takagi, M
    Ichijo, H
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (05) : 2769 - 2775
  • [50] Reversal of in vivo drug resistance by the transforming growth factor-beta inhibitor decorin
    Teicher, BA
    Maehara, Y
    Kakeji, Y
    Ara, G
    Keyes, SR
    Wong, J
    Herbst, R
    INTERNATIONAL JOURNAL OF CANCER, 1997, 71 (01) : 49 - 58